BNP Paribas Asset Management’s Legend Biotech LEGN Stock Holding History

BNP Paribas Asset Management’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$401K	Sell	22,145 -2,279	-9%	-$43.4K	﹤0.01%	1275
2025 Q4	$532K	Buy	+24,424	New	+$700K	﹤0.01%	1244
2025 Q3	–	Sell	-14,043	Closed	-$498K	–	1981
2025 Q2	$498K	Sell	14,043 -349	-2%	-$11.3K	﹤0.01%	799
2025 Q1	$488K	Buy	14,392 +918	+7%	+$32.9K	﹤0.01%	803
2024 Q4	$438K	Buy	13,474 +5,459	+68%	+$226K	﹤0.01%	842
2024 Q3	$391K	Buy	8,015 +1,451	+22%	+$77.3K	﹤0.01%	842
2024 Q2	$291K	Buy	6,564 +2,947	+81%	+$136K	﹤0.01%	927
2024 Q1	$203K	Buy	+3,617	New	+$218K	﹤0.01%	871

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

FBIL

First Beijing Investment Ltd Hong Kong $2.44B AUM 18.47% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

BNP Paribas Asset Management's LEGN Position: Q1 2026 in Review

BNP Paribas Asset Management reduced its Legend Biotech (LEGN) stake by 9.3% in Q1 2026, selling an estimated $43.4K and leaving 22,145 shares worth $401K. The position accounts for ﹤0.01% of the portfolio, ranked #1275.

BNP Paribas Asset Management first reported a position in LEGN in Q1 2024 and has held it in 8 quarters since. The position peaked at $532K in Q4 2025. 191 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

BNP Paribas Asset Management held 22,145 shares of Legend Biotech worth $401K as of Q1 2026.
BNP Paribas Asset Management sold 2,279 Legend Biotech shares in Q1 2026, an estimated $43.4K.
Legend Biotech made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q1 2026, its #1275 holding.
BNP Paribas Asset Management first reported a position in Legend Biotech in Q1 2024 and has held it in 8 quarters since.
BNP Paribas Asset Management's Legend Biotech position peaked at $532K in Q4 2025.
191 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.